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Population basedObjective: Chronic widespread pain and chronic fatigue share common associated factors but these associations
may be explained by the presence of concurrent depression and anxiety.
Methods:We mailed questionnaires to a randomly selected sample of people in the UK to identify participants
with chronic widespread pain (ACR 1990 deﬁnition) and those with chronic fatigue. The questionnaire assessed
sociodemographic factors, health status, healthcare use, childhood factors, adult attachment, and psychological
stress including anxiety and depression. To identify persons with unexplained chronic widespread pain or unex-
plained chronic fatigue; we examined participant's medical records to exclude medical illness that might cause
these symptoms.
Results: Of 1443 participants (58.0% response rate) medical records of 990 were examined. 9.4% (N = 93) had
unexplained chronic widespread pain and 12.6% (N = 125) had unexplained chronic fatigue. Marital status,
childhood psychological abuse, recent threatening experiences and other somatic symptoms were commonly
associated with both widespread pain and fatigue. No common effect was found for few years of education
and current medical illnesses (more strongly associated with chronic widespread pain) or recent illness in a
close relative, neuroticism, depression and anxiety scores (more strongly associated with chronic fatigue). Puta-
tive associated factors with a common effect were associated with unexplained chronic widespread pain or
unexplained chronic fatigue only when there was concurrent anxiety and/or depression.
Discussion: This study suggests that the associated factors for chronic widespread pain and chronic fatigue need
to be studied in conjunctionwith concurrent depression/anxiety. Clinicians should be aware of the importance of
concurrent anxiety or depression.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Chronic widespread pain and chronic fatigue are common and may
be disabling; they have complex aetiologies [1–8]. These functional so-
matic syndromes share common risk factors [9–12], a ﬁnding which
has been interpreted as suggesting that chronic widespread pain and
chronic fatigue aremanifestations of a single disorder [8]. An alternative
view is that they are separate syndromeswhich frequently co-occur and
this co-occurrence can be attributed to two dimensions, which have
separate genetic and environmental components: an affective compo-
nent (depression and anxiety) and a sensory component (especially
chronic widespread pain) [13,14]. Comorbid anxiety and depressionBeth).
. This is an open access article undercommonly occur in individuals with chronic fatigue and the risk factors
for chronic fatigue differ between those with, and those without, con-
current anxiety or depression [15]. It is plausible that the observation
of common associated factors across chronic fatigue and chronic wide-
spread pain is explained by co-morbid anxiety and depression. The
aim of this study was to test the hypothesis that the associated factors
commonly associated with both chronic widespread pain and chronic
fatigue would be explained by the presence of concurrent depression/
anxiety.
Methods
We conducted a cross-sectional population-based study. We mailed
2985 baseline questionnaires to people aged 25–65 years registered at
two general practices in North West England, one in an afﬂuent rural
area and one in a more deprived inner city area. Potential participantsthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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simple random sampling assuming that the sampled sub-group was
representative of the population from which they were drawn (Fig. 1).
Of those 2490were eligible to participate andwere sent a questionnaire
that assessed the presence of chronic widespread pain, chronic fatigue
and a number of potential associated factors (see below for details).
Written informed consent was sought to examine participant's
medical records. The aim of the medical record review was to identify
recorded general medical illness that could explain the presence of
pain or fatigue and to count the number of consultations over the year
prior to questionnaire completion. Non-responderswere sent a remind-
er postcard after two weeks and, if necessary, a further questionnaire
after two further weeks.Deﬁnition of symptom groups
Since our study did not include a medical examination whichwould
enable us to make a speciﬁc diagnosis, we refer to the relevant symp-
toms of pain and fatigue as “symptom groups”.Fig. 1. Flow of studChronic widespread pain
Participants were asked to report the presence of anymusculoskele-
tal pain they had experienced in the pastmonth,whether their pain had
persisted for three months or more, and to shade on a four-view blank
bodymanikin the location(s) of their pain. Using these data participants
satisfying the criteria for chronic widespread pain included in the
American College of Rheumatology 1990 criteria for ﬁbromyalgia
(pain above and below the waist, in the right and left hand sides of
the body and in the axial skeleton, present for at least three months)
[16] were identiﬁed.Chronic fatigue
The fatigue scale contains 11 items that inquire about symptoms of
physical and mental fatigue. Individual items are scored 0 or 1, with a
total score ranging from 0 to 11. Participants with fatigue scores of 4
or more on the Fatigue Scale [17] and who had reported symptoms for
six months or more were classiﬁed as having chronic fatigue.y participants.
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For participants who had agreed, medical records were reviewed for
12 months before and after the date of baseline questionnaire by two
raters (FC and CCG) to see if therewas evidence of a recognisedmedical
condition that could explain chronic fatigue or chronicwidespread pain.
A conservative approach was used; any medical illness that could cause
fatigue orwidespread pain led to exclusion from the symptomgroups of
unexplained fatigue or widespread pain so only those participants with-
out such a conditionwere classiﬁed as having chronic fatigue or chronic
widespread pain. Nearly half of thosewhohad reported fatigue orwide-
spread pain had consulted their GP with the relevant symptom and, of
these, one third had undergone investigations that would be helpful in
ruling out underlying organic disease.
Socio- demographic details
These included age, sex, marital status, current work status (includ-
ing disability status), number of years of formal education and details of
any outstanding compensation claims.
Co-morbid general medical illness
Respondents were asked if they had any common medical illnesses
on a checklist and add any not listed. For analysis, participants were
classiﬁed as having none, one, two or more general medical illnesses.
Other bodily symptoms
The Somatic Symptom Inventory (SSI) asks respondents to rate 13
bodily symptoms on a 5-point scale as to “how much it has bothered
you over the past 6 months?” The total score ranges from 13 to 65
with high scores indicating greater bother [18].
Childhood Factors
The Childhood Physical and Sexual Abuse questionnaire consists of 8
questions concerning abuse [19]. Respondents were rated as having ex-
perienced childhood abuse if, before the age of 16 years, they reported
that an older person touched them or they were made to touch some-
one else in a sexual way, or intercourse was attempted or completed
(sexual abuse); that they were hit, kicked or beaten often and/or their
lifewas seriously threatened (physical abuse); theywere often insulted,
humiliated or made to feel guilty (psychological abuse).
The Parental Bonding Instrument includes 7 questions concerning per-
ceived maternal care and 1 item concerning maternal control [20,21].
Adult attachment, recent stress and mental state
The Relationship Scales Questionnaire measures adult attachment
style by asking respondents to identify which of four sets of characteris-
ticsmost closelymatches theway they relate to other people [22]. These
are: secure (trusting in others), preoccupied (emotionally dependent,
low self-esteem), fearful (low trust of others, fearful of intimacy) and
dismissing (low trust in others, compulsively self-reliant).
Social Support was assessed with a question determining whether
the respondent had a close conﬁdant with whom they can discuss all
concerns.
The List of Threatening Experiences (LTE-Q) measures the experience
of 12 threatening personal situations or events in the last 6 months
[23]. The total score of positive responses represents recent exposure
to threatening experiences; we quote the results in 3 groups (0, 1, 2 or
more). We also quote separately the scores for questions regarding ill-
ness in the participant and close relatives.The Revised NEO Personality Inventory (NEO-PI-R) measures the per-
sonality trait of Neuroticism [24]. It has a maximum score of 48 with
high scores indicating higher levels of neuroticism.
The Hospital Anxiety and Depression Scale (HADS) is a valid and reli-
able measure of anxiety and depression in the general population
which avoids questions about physical symptoms (e.g. weight loss,
pain) that might be caused by general medical illness [25]. A score of
11 or more indicates probable disorder for each dimension but a total
HADS score (anxiety+depression) of 17+has been used also to detect
probable depressive disorder [26].
Health status and healthcare use
The Short Form 12 (SF12) Questionnaire assesses health status [27]. It
is a validated shortened version of the 36 itemversion and both versions
have been used in chronic fatigue and chronic widespread pain [28–31]
The 12 items yield summary scores formental (SF12-MCS) and physical
(SF12-PCS) components of health status, which are transformed into
norm based scoring (27). A low score represents impairment of health
status.
Healthcare use
For participantswho had agreed to a review of their medical records
we counted all consultations with the general practitioner or practice
nurse for 12 months before and after the baseline questionnaire.
The study received ethical approval from the North Manchester
Local Research Ethics Committee (REC reference number: 06/Q1406/
14). All participants provided written informed consent to participate
in the study.
Statistical analysis
Multi-level modelling was used to take into account that chronic
widespread pain and chronic fatigueweremeasured on each individual,
and these symptom groups may not be independent of each other. This
technique takes into account that the correlation of symptom groups
within individuals will be greater than that between individuals. Each
symptom group was thus treated as a within subject factor called
‘type’with two levels representing the two symptom groups. Other var-
iables measured at the subject level, such as childhood abuse and anxi-
ety and depression (the putative associated factors) were entered in
turn into a series of logistic regression analyses using the stata com-
mand xilogit, which included age and gender as between subject covar-
iates, and with symptom groups (yes/no) as the dependent variable.
Initially, symptom-speciﬁc associations were calculated using a popula-
tion average model. A term for the interaction between ‘type’ and the
associated factor was then added to the model, and a Wald test carried
out to investigate whether the strength of association of the associated
factor was similar across both symptoms, while taking into account
within subject correlation of having both symptoms. TheWald test pro-
vides p-values to assess the interaction of ‘type’with the associated fac-
tor. Therefore, small p-values (p ≤ 0.05) would indicate that differential
effects are likely, while larger p-values (p N 0.05) indicate that a com-
mon effect is plausible, in which case the common effect estimate was
obtained from the model. Common effect odds ratios are presented
only when the Wald test for the interaction between type of disorder
and the associated factor was not signiﬁcant. In this case common effect
odds ratioswere obtained using the stata command xtlogitwith age and
gender as covariates, but without the interaction term.Where the inter-
action was signiﬁcant ‘no common effect’ has been tabulated, and odds
ratios for that associated factor for chronic widespread pain and chronic
fatigue separately should be interpreted. These were obtained using the
stata command xtlogit with age and gender as additional covariates.
Scored variables, SSI, SF-12 mental and physical scores, neuroticism
and HADS scores have been split into 3 tertile groups in order to assist
Table 1
Individual and common effects between each putative risk factor and MUS (n = 990) 1, adjusted for age and sex. Odds ratios and 95% conﬁdence intervals.
CWP (n = 93) vs
no CWP (n = 897)
CF (n = 125) vs
no CF (n = 865)
Comparison Common effect
OR 95% CI OR 95% CI p OR 95% CI
Demographic details (N, %)
Age:
25–34 (166.17%) 1.0 Referent 1.0 Referent 1.0 Referent
35–44 (259,26%) 1.4 0.7–2.9 1.1 0.6–2.0 0.20 1.2 0.7–2.0
45–54 (238.24%) 0.9 0.4–2.0 0.9 0.5–1.6 0.9 0.5–1.5
≥ 55 (327.33%) 1.8 0.9–3.6 0.9 0.5–1.6 1.2 0.8–1.9
Female sex2 (549.56%) 1.1 0.7–1.7 1.2 0.8–1.8 0.69 1.1 0.8–1.6
Single (148.15%) 0.8 0.4–1.6 1.1 0.6–1.9 0.22 1.0 0.6–1.5
Married/cohabiting (732.74%) 1.0 Referent 1.0 Referent - 1.0 Referent
Separated/widowed/divorced (102.10%) 2.7 1.5–4.8 2.7 1.3–5.7 0.80 2.7 1.8–4.0
Less than 12 years of education (261.26%) 2.6 1.5–4.4 1.4 0.9–2.2 0.01 No common effect
No conﬁdant (64.6%) 1.4 0.6–3.1 3.1 1.6–6.0 0.09 2.2 1.3–3.6
Working (778.79%) 1.0 Referent 1.0 Referent - 1.0 Referent
Unemployed, and seeking work (18.2%) 2.2 0.6–7.7 2.7 0.6–13.1 0.69 2.4 1.0–5.9
Not working due to ill health (26.3%) 1.8 0.0–230 2.0 1.2–3.5 0.56 1.9 1.2–2.9
Student, retired, etc. (152.15%) 0.8 0.4–1.5 0.8 0.4–1.5 0.51 0.8 0.5–1.3
Off work due to ill health in the past month (111.11%) 1.9 1.1–3.4 2.3 1.4–3.8 0.53 2.1 1.4–3.1
Compensation claim (10.1%) 6.8 1.8–25.2 1.8 0.4–8.8 0.14 3.5 1.2–10.1
Health status and healthcare use
Somatic Symptom Index score:
b26 (787.80%) 1.0 Referent 1.0 Referent 1.0 Referent
26–30 (115.12%) 4.0 2.2–7.2 5.2 2.9–9.0 0.72 4.4 3.0–6.5
N30 (88.9%) 8.9 4.9–16.4 11.0 5.7–21.0 9.3 6.3–13.7
2 or more current medical illnesses (88.9%) 4.5 2.3–8.7 2.0 1.1–3.8 0.017 No common effect
SF-12 mental score:
≥50 (558.56%) 1.0 Referent 1.0 Referent
40–50 (217.22%) 1.2 0.7–2.2 3.3 1.7–6.3 b0.001 No common effect
b40 (215 (22%) 2.9 1.7–4.8 16.0 5.8–44.4
SF-12 physical score:
≥50,657.66%) 1.0 Referent 1.0 Referent 1.0 Referent
40–50 (186.19%) 3.4 1.9–5.9 2.1 1.3–3.5 0.72 2.5 1.7–3.7
b40 (147.15%) 5.3 3.0–9.4 4.7 2.9–7.8 4.7 3.3–6.8
No of consultations in primary care in the previous year:
0 (289.29%) 1.0 Referent 1.0 Referent 1.0 Referent
1 (203.21%) 1.4 0.7–2.7 2.1 1.1–3.9 0.60 1.7 1.1–2.8
2 or 3 (249.25%) 1.3 0.7–2.5 2.2 1.2–4.0 1.8 1.2–2.7
≥4 (187.19%) 2.6 1.4–4.8 3.1 1.6–5.8 2.8 1.8–4.4
Childhood factors
Maternal care score:
≥ 18 Good (522.53%) 1.0 Referent 1.0 Referent 1.0 Referent
15–18 Poor (222.22%) 1.3 0.8–2.2 1.2 0.7–1.9 0.19 1.2 0.8–1.8
0–14 Very poor (246.25%) 1.0 0.6–1.7 1.6 1.1–2.6 1.3 0.9–1.9
Maternal over-control 0.95 0.6–1.5 1.4 0.9–2.0 0.20 1.2 0.8–1.6
Any childhood abuse (65.7%) 1.9 0.9–4.1 2.0 0.98–4.0 0.84 1.9 1.2–3.2
Sexual abuse (113.11%) 1.6 0.8–2.9 1.9 1.2–3.2 0.55 1.7 1.1–2.7
Psychological abuse (51.5%) 2.3 1.05–5.2 2.3 1.1–4.8 0.92 2.2 1.3–3.9
Physical abuse (35.4%) 2.1 0.8–5.7 2.2 0.9–5.4 0.96 2.1 1.1–4.0
Loss of mother b16 yrs. (22.2%) 2.1 0.7–6.5 2.1 0.7–6.3 0.94 2.1 0.9–4.7
Loss of father b16 yrs. (52.5%) 2.1 0.9–4.7 0.9 0.4–2.2 0.10 1.4 0.7–2.5
Adult attachment, recent stress and current mental state
Fearful attachment (143.14%) 1.5 0.9–2.7 2.5 1.5–4.0 0.12 2.0 1.4–2.9
Preoccupied attachment (71.7%) 1.3 0.6–2.8 2.4 1.3–4.3 0.15 1.9 1.1–3.1
Dismissing attachment (216.22%) 1.5 0.92–2.5 0.9 0.5–1.4 0.046 No common effect
Recent serious illness or injury to the participant (65.7%) 3.0 1.5–5.8 2.8 1.5–5.3 0.82 2.8 1.8–4.5
Recent serious illness or injury to a close relative (228.23%) 1.2 0.8–2.0 2.3 1.5–3.5 0.034 No common effect
Death of close relative (51.5%) 1.5 0.7–3.6 2.8 1.5–5.5 0.23 2.2 1.3–3.8
Death of close friend (158.16%) 1.6 0.9–2.6 1.6 0.96–2.6 0.88 1.5 1.1–2.3
Threatening experiences:
None (478.48%) 1.0 Referent 1.0 Referent 1.0 Referent
One (278.28%) 1.4 0.8–2.3 1.9 1.2–3.1 0.16 1.6 1.1–2.4
Two or more (232.23%) 2.2 1.3–3.6 4.0 2.5–6.3 3.0 2.1–4.3
Neuroticism score:
0–11 (270.27%) 1.0 Referent 1.0 Referent
12–17 (261.26%) 1.8 0.9–3.7 1.9 0.8–4.8
18–24 (232.23%) 2.3 1.1–4.6 5.8 2.2–15.3 b0.001 No common effect
N24 (227.23%) 3.4 1.7–6.8 16.6 3.7–73.7
HADS anxiety score:
0–7 (664.67%)
8–10 (185.19%)
1.0
2.0
Referent
1.2–3.5
1.0
4.1
Referent
2.5–6.9 0.011 No common effect
(continued on next page)
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Table 1 (continued)
CWP (n = 93) vs
no CWP (n = 897)
CF (n = 125) vs
no CF (n = 865)
Comparison Common effect
OR 95% CI OR 95% CI p OR 95% CI
≥11 (141.14%) 3.9 2.2–6.9 9.3 5.3–16.4
HADS depression score:
0–7 (900.91%) 1.0 Referent 1.0 Referent
8–10 (56.6%) 2.9 1.4–6.2 6.0 3.0–11.9 0.031 No common effect
≥11 (34.3%) 3.7 1.5–8.8 11.5 4.7–28.1
1 Excludes subjects with missing data.
2 adjusted for age only.
MUS Medically Unexplained Symptoms.
CWP = chronic widespread pain, CF = chronic fatigue.
OR = odds ratio, 95% CI = 95% conﬁdence interval for odds ratio.
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with anxiety, depression and number of general illnesses as covariates
in addition to age and gender.
Participants classiﬁed as having chronic widespread pain or chronic
fatiguewere then further divided into thosewith (HADS score ≥ 17) and
without (HADS score b 17) anxiety and/or depression [26]. The associ-
ated factors that were observed to be signiﬁcantly common in both
symptom groupswere then compared across the three resulting groups
(a) symptom plus anxiety and/or depression, b) symptom without
anxiety and/or depression and c) no symptom, using the chi-squared
test for dichotomous variables and one-way ANOVA for continuous
scores, followed by Bonferroni pairwise comparisons between groups.
This was then repeated for 4 factors which did not show a common
effect across both symptom groups.
Results
Participation rates
Of the 2490 questionnaires mailed, 1999 were returned (return rate
80.3%) of which 556 (22.3%)were blank or did not contain usable infor-
mation (see Fig. 1). The response rate was similar in the two practices
(62% inner city and 66.3% rural area). A total of 1443 (58.0%) partici-
pants returned a completed questionnaire and participated in the
study. Non-responders were signiﬁcantly more likely to be male
(53.1% versus 42.3%), and younger (mean = 43.9 versus 47.0 years)
than the remaining eligible participants. The participation rates at the
two practises were similar (56.3% and 59.3%).
We examined 990 medical records of the 992 (69%) participants
who gave permission for this. Those who refused permission were
younger (45.8 v 47.5 years, p = 0.013) and more likely to be female
(63.2% v 55.5%, p = 0.008) but did not differ in terms of marital status,
years of education, unemployment, prevalence of chronic widespread
pain or chronic fatigue by questionnaire or anxiety, depression or so-
matic symptoms scores. Completed follow up questionnaires were re-
ceived from 741 (75% of the 989 who agreed), of whom 638 (86.1%)
also had their medical notes examined (Fig. 1) but these data are not
used in this paper [2].
Prevalence of each symptom group
After exclusions because of missing data (chronic widespread pain
[n = 5] or chronic fatigue [n = 6)]), 159 (11.1%) participants fulﬁlled
criteria for chronic widespread pain and 229 (15.9%) had chronic fa-
tigue. Of the 990 participants with medical record review, the preva-
lence ﬁgures were similar: 11.4% (n = 113, 95% CI 9.5 to 13.4) and
15.5% (n = 153, 95% CI 13.2 to 17.7) respectively, but 20 (17.7%) cases
of chronic widespread pain and 28 (18.3%) cases of chronic fatigue
could be attributed to a co-existing general medical illness. The preva-
lence of unexplained chronic widespread pain was 9.4% (n = 93, 95%
CI 7.6 to 11.2), and chronic fatigue 12.6% (n = 125, 95% CI 10.6 to14.7) and our analyses concerned these participants who fulﬁlled
criteria for the unexplained symptom deﬁnitions. Mean SF-12 physical
component scores were 42.4 (SD = 10.9) and 43.3 (SD = 11.8) for
chronic widespread pain and chronic fatigue, respectively, indicating
impaired health status.
Associated factors and common effects
The majority of the putative associated factors were associated with
both chronic fatigue and chronic widespread pain and showed a com-
mon effect. The factors associated with a 2 or more fold increased
odds across both symptom groups included: being separated, widowed
or divorced, unemployed and seeking work, reported psychological
abuse during childhood, reported physical abuse during childhood,
loss of mother at age b 16, experience of a recent serious illness or inju-
ry, two or more recent threatening experiences, and a high somatic
symptom score (Table 1). Frequent consultations in primary care and
a low SF-12 physical component score (indicating impairment) were
common to both symptom groups.
A number of factors showed no common effect. Fewer than 12 years
of formal education and 2 or more current general medical illnesses
were both more strongly associated with chronic widespread pain
than with chronic fatigue. Recent serious illness or injury to a close
relative was strongly associated with the presence of chronic fatigue
but not chronic widespread pain. There was also no common effect of
neuroticism, depression, anxiety and SF-12 mental component scores
with the stronger relationship observed for those participants with
chronic fatigue.
After adjusting for anxiety, depression and number of general med-
ical illnesses, in addition to age and gender, these results remained
similar.
Association with anxiety and depression
The proportion of participants with concurrent anxiety and depres-
sion (HADS total score of 17 or more) was 41.6% of participants with
chronic fatigue (52/125) and 24.7% of those with chronic widespread
pain (23/93), p = 0.010.
Concurrent depression/anxiety
Associated factors with common effect
The putative associated factors which showed a common effect
(childhood psychological abuse, separated/widowed/divorced, recent
serious illness/injury and 2 or more threatening life events) were
more common in participants with chronic fatigue or widespread pain
who reported concurrent anxiety and/or depression compared to par-
ticipantswith these symptoms alone (Fig. 2a). Approximately 5% of par-
ticipants with chronic widespread pain or chronic fatigue without
concurrent anxiety and/ordepression reported psychological abuse,
which was similar to participants free of chronic widespread pain or
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symptoms plus concurrent anxiety and/or depression (approximately
20%). A similar pattern was found with the other putative associated
factors that had a common effect (Fig. 2a).
Associated factors with no common effect
The pattern of association was different for putative associated fac-
tors with no common effect (Fig. 2b). Nearly half of participants with
chronic widespread pain had received 12 or fewer years of formal edu-
cation, whether or not there was concurrent anxiety and/or depression;
this compared to a quarter of participants without chronic widespread
pain. In chronic fatigue there was no signiﬁcant difference in duration
of education between the 3 groups (Fig. 2b).
Over half of participants (53.8%) with chronic widespread pain and
concurrent anxiety and/or depression had 2 ormore recognised general
medical illnesses; this compared with 32% of those with chronic wide-
spread pain without anxiety and/or depression, and 11% of those with-
out chronic widespread pain. Of participants with chronic fatigue and
anxiety and/or depression31.2% had 2 ormore generalmedical illnesses
compared to 14.3% of thosewith chronic fatigue alone and 13%of partic-
ipants without chronic fatigue.
Recent serious illness or injury in a close relative was reported more
frequently by participantswith chronic fatigue, whether or not they had
concurrent anxiety and/or depression (approximately 38%) compared
to those without the symptom groups (21.0%). There was no signiﬁcant
difference in chronic widespread pain (Fig. 2b).
Mean neuroticism scores in participants with chronic widespread
pain without anxiety or depression were similar to those free of chronic
widespread pain (17.0 [SD = 9.1] and 17.4 [7.5]); this score was lower
than that for participantswith chronicwidespreadpainwith concurrent
anxiety and/or depression (32.6 [6.7]). Participants with chronic fatigue
alone, on the other hand, had ameanneuroticism score signiﬁcantly dif-
ferent from those without this symptom (21.2 [SD = 8.1] v 16.3 [8.7]:
p b 0.001 Bonferroni) (Fig. 2b).
Discussion
Summary of main ﬁndings in the context of current knowledge
This is the ﬁrst study to show that the putative associated factors for
chronic fatigue and chronic widespread pain were not associated with
each symptom in an identical fashion. The factors which appear to be
common to each of these were only associated with them when there
was also concurrent anxiety and depression. For example, although fa-
tigue and chronic widespread pain each showed an association with re-
ported childhood psychological abuse, this could be attributed to the
presence of anxiety or depression rather than a true correlate of the fa-
tigue or widespread pain.
Similar ﬁndings were reported in a birth cohort study where adjust-
ment for psychopathology led to childhood physical abuse becoming
non-signiﬁcant as a risk marker of CFS-like illness [1]. Rather similar
effects were found in a study of widespread pain: adjustment for PTSD
led to the prior experience of witnessing a traumatic event becoming
non-signiﬁcant [32].We found also that threatening life events were as-
sociated with chronic fatigue and widespread pain only in the presence
of concurrent anxiety or depression; the association with chronic fa-
tigue has been reported previously in two prospective cohort studies
[15,33,34]. This pattern of associations also held for previously married
status and reported childhood psychological abuse in both chronic
fatigue and chronic widespread pain. Our ﬁnding that neuroticism
scores were raised in participants with chronic fatigue, whether or not
there was accompanying anxiety and/or depression is similar to that
concerning chronic fatigue in one birth cohort study [15].
Our results extend those of our previous study of common associat-
ed factors across these symptom groups [10] because we widened the
range of possible associated features and found new features that didnot have a common effect - duration of education, current generalmed-
ical illnesses, having an ill relative and neuroticism. Although they were
shown to have a common effect, depression and anxiety were much
more closely associated with chronic fatigue than the other symptoms
groups in our previous study [10].
The association between chronic widespread pain and few years of
education and generalmedical illness appears to be independent of psy-
chiatric disorder. This has been reported previously but ours is the ﬁrst
demonstration of the contrast between chronic widespread pain and
chronic fatigue in this respect [35,36]. Whether the relationship with
few years of education is a speciﬁc or general effect is not known [37].
Strengths and limitations
Our study has a number of strengths as it used well-recognised case
deﬁnitions of chronic fatigue and chronic widespread pain in a
population-based sample rather than self-described chronic fatigue or
attenders at primary care [15,38]. We excluded cases where the fatigue
or pain could be explained by recognised organic disease, which has
been done only in some previous population-based studies. On the
other hand, we did not use an interviewer-based detailed deﬁnition of
chronic fatigue preventing us from extrapolating our ﬁndings to this
smaller group of the more severe chronic fatigue syndrome. This is im-
portant as childhood physical abusewas an associated factor for chronic
fatigue syndrome/ME in the cohort studywhich did not ﬁnd this associ-
ation in CFS-like illness once psychopathology was adjusted for [1]. This
suggests subtle differences according to the symptom group studied
and the way associated factors and psychopathology are deﬁned and
measured [3,39,40]. It is worth noting that chronic fatigue is much
more common and relevant to primary care, than chronic fatigue syn-
drome [41]. We also relied on a self-administered questionnaire to as-
sess childhood abuse and this may not be the most reliable method.
Our study was limited as our main analysis was cross-sectional,
preventing true assessment of risk factors. Larger prospective studies,
however, have found also that neuroticism and depression are predic-
tors of subsequent chronic fatigue [15,42]. Others found that few years
of education and one or more longstanding physical disease predicted
later onset of chronic pain [35].
Interpretation of our results
Although our method was quite different, our ﬁndings support the
suggestion from twin studies that concurrence of functional somatic
syndromes can be explained, in part, by two latent traits— one primar-
ily psychiatric and one sensory or pain component [11,13].We found no
association between reported childhood psychological abuse and
chronic widespread pain or fatigue in the absence of anxiety or depres-
sion, suggesting that this is not a true associated factor for these symp-
tomgroups but only applicablewhen there is concurrent anxiety and/or
depression [33,44,45]. This may explain why results concerning sexual
abuse as a common associated factor for chronic fatigue syndrome are
inconsistent [33,43,46].
Since our studywas cross-sectionalwe cannot comment on the tem-
poral relationship between chronic fatigue orwidespread pain and anx-
iety and/or depression but others have found that depression precedes
fatigue and vice versa [33,34,42]. It is most likely that there are different
pathophysiological pathways to chronic fatigue syndrome [33,38,47].
Our data suggest that some of the putative associated factors for chronic
fatigue and chronic widespread pain are, in fact, associated factors for
the concurrent anxiety or depression frequently observed with these
symptoms. It is possible however that anxiety or depressionmay repre-
sent one pathway to chronic fatigue, in particular.
The implications of our study are twofold. From the research per-
spective, our difﬁculty in understanding the aetiology of the functional
somatic syndromes will remain while the cause of each symptom
group or syndrome is sought as a single entity. Instead, our data suggest
Fig. 2. a comparison of symptom groups with and without anxiety/depression: risk factors with a common effect across the symptoms. Fig. 2b comparison of symptom groups with and
without anxiety/depression: risk factors without a common effect across the symptoms.
490 J. McBeth et al. / Journal of Psychosomatic Research 79 (2015) 484–491that the search for causes should look at common aetiological factors
across different functional somatic syndromes, notably those associated
with psychiatric disorders, simultaneously with the unique associated
factors for each syndrome [48]. Another, similar approach is to compare
the aetiological pathways of multiple somatic symptoms and multiple
syndromes with those of discreet syndromes [48].
From the clinical perspective, it is helpful for clinicians and patients
to know that the presence of a chronic fatigue or chronic widespread
pain does not necessarily imply a history of abuse or psychiatric disor-
der. Such implications may get in the way of satisfactory consultations
and care. On the other hand it should be routine that clinicians explore
these issues with all patients who have a functional somatic syndrome,
including case-ﬁnding for anxiety anddepression, and discuss appropri-
ate management options if relevant. Current evidence suggests thatseparate treatments for somatic symptoms and psychiatric symptoms
are helpful. The former often involves speciﬁc cognitive behaviour ther-
apy aimed at beliefs related to somatic symptoms and/or some form of
exercise [49–52]; the latter often involves a psychological treatment for
anxiety or depression and/or antidepressant therapy as described in
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